XALACOM (latanoprost-timolol) Indications And Clinical Use

Medical Information
Canada
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

This content is intended for Canadian Healthcare Professionals. Would you like to proceed?

XALACOM (latanoprost and timolol maleate) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-adrenergic blocking agents, prostaglandins, or other IOP lowering agents AND when the use of XALACOM (the combination drug) is considered appropriate.

XALACOM should not be used to initiate therapy.

For details of information obtained from Clinical Trials with XALACOM, please refer to CLINICAL TRIALS section.  Also see DOSAGE AND ADMINISTRATION.